TET1 inhibits the migration and invasion of cervical cancer cells by regulating autophagy

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–15. doi: 10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Maver PJ, Poljak M. Progress in prophylactic human papillomavirus (HPV) vaccination in 2016: a literature review. Vaccine. 2018;36(36):5416–23. doi: 10.1016/j.vaccine.2017.07.113
   PubMed Web of Science ®Google Scholar
• Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16(1):1–17. doi: 10.1128/CMR.16.1.1-17.2003
   PubMed Web of Science ®Google Scholar
• Woodman CB, Collins SI, Young LS. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer. 2007;7(1):11–22. doi: 10.1038/nrc2050
   PubMed Web of Science ®Google Scholar
• Su PH, Lai HC, Huang RL, et al. Paired box-1 (PAX1) activates multiple phosphatases and inhibits kinase cascades in cervical cancer. Sci Rep. 2019;9(1):9195. doi: 10.1038/s41598-019-45477-5
   PubMedGoogle Scholar
• Gong Y, Wan JH, Zou W, et al. MiR-29a inhibits invasion and metastasis of cervical cancer via modulating methylation of tumor suppressor SOCS1. Future Oncol. 2019;15(15):1729–44. doi: 10.2217/fon-2018-0497
   PubMed Web of Science ®Google Scholar
• Hu Y, Wu F, Liu Y, et al. DNMT1 recruited by EZH2-mediated silencing of miR-484 contributes to the malignancy of cervical cancer cells through MMP14 and HNF1A. Clin Epigenetics. 2019;11(1):186. doi: 10.1186/s13148-019-0786-y
   PubMed Web of Science ®Google Scholar
• Liu W, Wu G, Xiong F. et al. Advances in the DNA methylation hydroxylase TET1. Biomark Res. 2021 [cited 2021 Oct 16];9(1):76. doi: 10.1186/s40364-021-00331-7
   PubMed Web of Science ®Google Scholar
• Greenberg MVC, Bourc’his D. The diverse roles of DNA methylation in mammalian development and disease. Nat Rev Mol Cell Biol. 2019;20(10):590–607. doi: 10.1038/s41580-019-0159-6
   PubMed Web of Science ®Google Scholar
• Joshi K, Liu S, Breslin SJP, et al. Mechanisms that regulate the activities of TET proteins. Cell Mol Life Sci. 2022;79(7):363. doi: 10.1007/s00018-022-04396-x
   PubMed Web of Science ®Google Scholar
• Charlton J, Jung EJ, Mattei AL, et al. Tets compete with DNMT3 activity in pluripotent cells at thousands of methylated somatic enhancers. Nat Genet. 2020;52(8):819–27. doi: 10.1038/s41588-020-0639-9
   PubMed Web of Science ®Google Scholar
• Lu Y, Zhang R, Zhang X, et al. Curcumin may reverse 5-fluorouracil resistance on colonic cancer cells by regulating TET1-NKD-Wnt signal pathway to inhibit the EMT progress. Biomed Pharmacother. 2020;129:110381. doi: 10.1016/j.biopha.2020.110381
   PubMed Web of Science ®Google Scholar
• Thomson JP, Ottaviano R, Unterberger EB, et al. Loss of Tet1-associated 5-hydroxymethylcytosine is concomitant with aberrant promoter hypermethylation in liver cancer. Cancer Res. 2016;76(10):3097–108. doi: 10.1158/0008-5472.CAN-15-1910
   PubMed Web of Science ®Google Scholar
• Guo H, Zhu H, Zhang J, et al. TET1 suppresses colon cancer proliferation by impairing beta-catenin signal pathway. J Cell Biochem. 2019;120(8):12559–12565. doi: 10.1002/jcb.28522
   PubMed Web of Science ®Google Scholar
• Fu R, Ding Y, Luo J, et al. Ten-eleven translocation 1 regulates methylation of autophagy-related genes in human glioma. Neuroreport. 2018;29(9):731–8. doi: 10.1097/WNR.0000000000001024
   PubMed Web of Science ®Google Scholar
• Huang H, Jiang X, Li Z, et al. TET1 plays an essential oncogenic role in MLL-rearranged leukemia. Proc Natl Acad Sci U S A. 2013;110(29):11994–9. doi: 10.1073/pnas.1310656110
   PubMed Web of Science ®Google Scholar
• Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell. 2004;6(4):463–477. doi: 10.1016/S1534-5807(04)00099-1
   PubMed Web of Science ®Google Scholar
• Cuervo AM. Autophagy: in sickness and in health. Trends Cell Biol. 2004;14(2):70–77. doi: 10.1016/j.tcb.2003.12.002
   PubMed Web of Science ®Google Scholar
• Fan J, Zhang Y, Mu J, et al. TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells. Clin Epigenetics. 2018;10(1):103. doi: 10.1186/s13148-018-0535-7
   PubMedGoogle Scholar
• Kang KA, Piao MJ, Hyun YJ, et al. Luteolin promotes apoptotic cell death via upregulation of Nrf2 expression by DNA demethylase and the interaction of Nrf2 with p53 in human colon cancer cells. Exp Mol Med. 2019;51(4):1–14. doi: 10.1038/s12276-019-0238-y
   Web of Science ®Google Scholar
• Neri F, Dettori D, Incarnato D, et al. TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway. Oncogene. 2015;34(32):4168–76. doi: 10.1038/onc.2014.356
   PubMed Web of Science ®Google Scholar
• Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24(8):560–575. doi: 10.1038/s41580-023-00585-z
   PubMed Web of Science ®Google Scholar
• Levine B, Kroemer G. Biological functions of autophagy genes: a disease perspective. Cell. 2019;176(1–2):11–42. doi: 10.1016/j.cell.2018.09.048
   PubMed Web of Science ®Google Scholar
• Liu L, Wu Y, Li Q, et al. METTL3 promotes Tumorigenesis and metastasis through BMI1 m6A methylation in oral squamous cell carcinoma. Mol Ther. 2020;28(10):2177–2190. doi: 10.1016/j.ymthe.2020.06.024
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Furumichi M, Sato Y, et al. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51(D1):D587–D592. doi: 10.1093/nar/gkac963
   PubMed Web of Science ®Google Scholar
• Wu J, Li H, Shi M, et al. TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells. J Exp Clin Cancer Res. 2019;38(1):348. doi: 10.1186/s13046-019-1334-5
   PubMed Web of Science ®Google Scholar
• Pei YF, Tao R, Li JF, et al. Liu BY.TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression. Oncotarget. 2016;7(21):31322–31335. doi: 10.18632/oncotarget.8900
   PubMedGoogle Scholar
• Tsai KW, Li GC, Chen CH, et al. Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype. Breast Cancer Res Treat. 2015;153(1):219–234. doi: 10.1007/s10549-015-3525-x
   PubMed Web of Science ®Google Scholar
• Sjöström M, Zhao SG, Levy S, et al. The 5-hydroxymethylcytosine landscape of prostate cancer. Cancer Res. 2022;82(21):3888–3902. doi: 10.1158/0008-5472.CAN-22-1123
   PubMed Web of Science ®Google Scholar
• Bao B, Teslow EA, Mitrea C, et al. Role of TET1 and 5hmC in an obesity-linked pathway driving cancer stem cells in triple-negative breast cancer. Mol Cancer Res. 2020;18(12):1803–1814. doi: 10.1158/1541-7786.MCR-20-0359
   PubMed Web of Science ®Google Scholar
• Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 2019;29(3):212–226. doi: 10.1016/j.tcb.2018.12.001
   PubMed Web of Science ®Google Scholar
• Goossens S, Vandamme N, Van Vlierberghe P, et al. EMT transcription factors in cancer development re-evaluated: beyond EMT and MET. Biochim Biophys Acta Rev Cancer. 2017;1868(2):584–591. doi: 10.1016/j.bbcan.2017.06.006
   PubMed Web of Science ®Google Scholar
• Li X, He S, Ma B. Autophagy and autophagy-related proteins in cancer. Mol Cancer. 2020 Jan 22;19(1):12.
   PubMed Web of Science ®Google Scholar
• Marsh T, Debnath J. Autophagy suppresses breast cancer metastasis by degrading NBR1. Autophagy. 2020;16(6):1164–1165. doi: 10.1080/15548627.2020.1753001
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Petroni G, Amaravadi RK, et al. Autophagy in major human diseases. EMBO J. 2021;40(19):e108863. doi: 10.15252/embj.2021108863
   PubMed Web of Science ®Google Scholar
• Zeng J, Jing Y, Shi R, et al. Autophagy regulates biliary differentiation of hepatic progenitor cells through Notch1 signaling pathway. Cell Cycle. 2016;15(12):1602–10. doi: 10.1080/15384101.2016.1181234
   PubMed Web of Science ®Google Scholar
• Lin TY, Chan HH, Chen SH, et al. BIRC5/Survivin is a novel ATG12-ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells. Autophagy. 2020;16(7):1296–1313. doi: 10.1080/15548627.2019.1671643
   PubMed Web of Science ®Google Scholar
• Hill SM, Wrobel L, Ashkenazi A, et al. VCP/p97 regulates beclin-1-dependent autophagy initiation. Nat Chem Biol. 2021;17(4):448–455. doi: 10.1038/s41589-020-00726-x
   PubMed Web of Science ®Google Scholar
• Fu R, Ding Y, Luo J, et al. TET1 exerts its tumour suppressor function by regulating autophagy in glioma cells. Biosci Rep. 2017;37(6). doi: 10.1042/BSR20160523
   Google Scholar